Mizuho Securities USA’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.46M Sell
23,267
-5,131
-18% -$357K 0.03% 456
2025
Q4
$1.8M Sell
28,398
-164
-0.6% -$10.6K 0.03% 449
2025
Q3
$2.15M Buy
28,562
+1,466
+5% +$116K 0.04% 398
2025
Q2
$2.37M Sell
27,096
-4,187
-13% -$328K 0.05% 354
2025
Q1
$2.14M Sell
31,283
-5,737
-15% -$468K 0.05% 373
2024
Q4
$2.88M Buy
37,020
+11,035
+42% +$817K 0.05% 343
2024
Q3
$1.74M Sell
25,985
-4,679
-15% -$384K 0.04% 379
2024
Q2
$3.48M Buy
+30,664
New +$3.88M 0.08% 237
2019
Q4
Sell
-32,800
Closed -$1.22M 173
2019
Q3
$1.22M Buy
+32,800
New +$1.27M 0.07% 87
2019
Q1
Sell
-38,400
Closed -$1.15M 120
2018
Q4
$1.15M Buy
+38,400
New +$1.22M 0.15% 74

Other funds holding DXCM

Mizuho Securities USA's DXCM Position: Q1 2026 in Review

Mizuho Securities USA reduced its DexCom (DXCM) stake by 18% in Q1 2026, selling an estimated $357K and leaving 23,267 shares worth $1.46M. The position accounts for 0.03% of the portfolio, ranked #456.

Mizuho Securities USA first reported a position in DXCM in Q4 2018 and has held it in 10 quarters since. The position peaked at $3.48M in Q2 2024. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Mizuho Securities USA held 23,267 shares of DexCom worth $1.46M as of Q1 2026.
  • Mizuho Securities USA sold 5,131 DexCom shares in Q1 2026, an estimated $357K.
  • DexCom made up 0.03% of Mizuho Securities USA's portfolio in Q1 2026, its #456 holding.
  • Mizuho Securities USA first reported a position in DexCom in Q4 2018 and has held it in 10 quarters since.
  • Mizuho Securities USA's DexCom position peaked at $3.48M in Q2 2024.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Mizuho Securities USA's 13F filing for Q1 2026, filed 11 May 2026.